Optimization of Formulation Variables of Benzocaine Liposomes using Experimental Design

References

• Anderson M., Omri A. The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Delivery 2004; 11: 33–39
   PubMed Web of Science ®Google Scholar
• Barclay L., Vega C. Methaemoglobinaemia linked to topical benzocaine use. Arch Intern Med 2004; 164: 1192–1195
   PubMedGoogle Scholar
• Broudiscou A., Leardi R., Phan-Tan-Luu R. Genetic algorithm as a tool for selection of D‐optimal design. Chem Intell Lab Sys 1996; 35: 105–116
   Web of Science ®Google Scholar
• Bucalo B.D., Mirikitani E.J., Moy R.L. Comparison of skin anaesthetic effect of liposomal lidocaine, nonliposomal lidocaine and EMLA using 30-minute application time. Dermatol Surg 1998; 24: 537–541
   PubMed Web of Science ®Google Scholar
• Covino B.G., Vassallo H. Local anaesthetics: mechanisms of action and clinical use. Grune and Stratton (Eds), New York 1976
   Google Scholar
• El Samaligy M.S., Afifin N., Mahmoude E.A. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 2006; 308: 140–148
   Google Scholar
• Fang J., Hwang T., Huang Y., Fang C. Enhancement of transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006; 310: 131–138
   PubMed Web of Science ®Google Scholar
• Fisher R., Hung O., Mezei R., Stewart M. Topical anaesthesia of intact skin: liposome-encapsulated tetracaine vs EMLA. Br J Anaest 1998; 81: 972–973
   PubMed Web of Science ®Google Scholar
• Fresta M., Puglisi G. Application of liposomes as potential cutaneous drug delivery systems: in vitro and in vivo investigation with radioactivity labelled vesicles. J Drug Target 1996; 4: 95–101
   PubMed Web of Science ®Google Scholar
• Furlanetto S., Cirri M., Maestrelli F., Corti G., Mura P. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. Eur J Pharm Biopharm 2006; 62: 77–84
   PubMed Web of Science ®Google Scholar
• Gabrielsson J., Lindberg N.O., Lundstedt T. Multivariate methods in pharmaceutical applications. J Chemometrics 2002; 16: 141–160
   Web of Science ®Google Scholar
• Ghelardini C., Galeotti N., Di Cesare Mannelli L., Mazzanti G., Bartolini A. Local anaesthetic activity of β- caryophyllene. Il Farmaco 2001; 56: 387–389
   PubMedGoogle Scholar
• Grant G.J., Bansinath M. Liposomal delivery systems for local anaesthetics. Reg Anesth Pain Med 2001; 26: 61–63
   PubMed Web of Science ®Google Scholar
• Kirjavainen M., Urtti A., Jaaskelainen I., Suhonen T.M., Paronen P., Valjakka-Koskela R., Kiesvaara J., Monkkonen J. Interaction of liposomes with human skin in vitro–the influence of lipid composition and structure. Biochim Biophys Acta 1996; 1304: 179–189
   PubMed Web of Science ®Google Scholar
• Kirjavainen M., Urtti A., Valjakka-Koskela R., Kiesvaara J., Monkkonen J. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999; 7: 279–286
   PubMed Web of Science ®Google Scholar
• Lewis G.A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical experimental design. Marcel Dekker (ed), New York 1999
   Google Scholar
• Lim J.O., Kim S.J., Pouliot R., Baek W.Y. Enhanced transdermal delivery of local anaesthetics by liposome formulation of local anaesthetic mixture. Trans Tech Publ 2005; 277: 45–50
   Google Scholar
• López-Pinto J.M., Gonzalez-Rodriguez M.L., Rabasco A.M. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 2005; 298: 1–12
   PubMed Web of Science ®Google Scholar
• Maestrelli F., González-Rodríguez M.L., Rabasco A.M., Mura P. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 2005; 298: 55–67
   PubMed Web of Science ®Google Scholar
• Margalit R. Liposome-mediated drug targeting in topical and regional therapies. Crit Rev Ther Drug Carrier Syst 1995; 12: 233–261
   PubMed Web of Science ®Google Scholar
• Mezei M., Gulasekharam V. Liposomes, a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 1982; 34: 473–474
   PubMed Web of Science ®Google Scholar
• Mohammed A.R., Weston N., Coombes A.G.A., Fitzgerald M., Perrie Y. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 2004; 285: 23–34
   PubMed Web of Science ®Google Scholar
• Mura P., Celesti L., Murratzu C., Corsi S., Furlanetto S., Corti P. In vitro studies of simulated percutaneous absorption: influence of artificial membrane impregnation agent. Acta Techn Leg Med 1993; 4: 121–136
   Google Scholar
• Mura P., Maestrelli F., Michelacci I., Ghelardini C., Gonzalès M.L., Rabasco A. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 2007; 67: 86–95
   PubMed Web of Science ®Google Scholar
• Seth A.K., Misra A. Matematical modelling of preparation of acyclovir liposomes: reverse phase evaporation method. J Pharm Pharmaceut Sci 2002; 5: 285–291
   PubMed Web of Science ®Google Scholar
• Sun X., Zhang Z. Optimizing the novel formulation of liposome-polycation-DNA complexes (LPD) by central composite design. Arch Pharm Res 2004; 27: 797–805
   PubMed Web of Science ®Google Scholar
• Touitou E., Alkabes M., Dayan N., Elbaz M. Ethosomes: novel vesicular carriers for enhanced skin delivery. Pharm Res 1997; 14: 305–306
   Google Scholar
• Trotta M., Peira E., Carlotti M.E., Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm. 2004; 270: 119–125
   PubMed Web of Science ®Google Scholar
• Verma D.D., Verma S., Blume G., Fahr A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 2003; 55: 271–277
   PubMed Web of Science ®Google Scholar
• Webb M.S., Wheeler J.J., Bally M.B., Mayer L.D. Cationic lipid stearylamine reduces permeability of cationic drugs verapamil and prochlorperazine to lipid bilayer: implications for drug delivery. Biochim Biophys Acta 1995; 1238: 147–155
   PubMed Web of Science ®Google Scholar